|
Medical Advocates Cryptococcosis |
|
|
|
|
|
Posaconazole |
|
Journal Papers, Abstracts, and Commentaries |
|
Posaconazole and amphotericin B combination therapy against Cryptococcus
neoformans infection. Barchiesi F, Spreghini E, Schimizzi AM, et al Antimicrob Agents Chemother. 2004 Sep;48(9):3312-6. Abstract |
|
Saquinavir |
|
Journal Papers, Abstracts, and Commentaries |
|
Interaction between saquinavir and antimycotic drugs on C. albicans and C.
neoformans strains. Casolari C, Rossi T, Baggio G, Coppi A, Pharmacol Res. 2004 Dec;50(6):605-10. Abstract |
|
Voriconazole |
|
Journal Papers, Abstracts, and Commentaries |
Voriconazole treatment for less-common, emerging, or refractory fungal
infections. |
|
Azoles: General Reports |
|
Journal Papers, Abstracts, and Commentaries |
|
antiretroviral therapy: evidence for primary azole prophylaxis. Caney P, Stephens D, Rimland D. HIV Med. 2005 Jul;6(4):253-9 Abstract |
|
Antifungals: General Reports |
|
Journal Papers, Abstracts, and Commentaries |
|
Antifungal interventions for the primary prevention
of cryptococcal disease in adults with HIV. Chang L, Phipps W, Kennedy G, Rutherford G. Cochrane Database Syst Rev. 2005 Jul 20;(3):CD004773. Abstract |
|
Antiretrovirals: General Reports |
|
Journal Papers, Abstracts, and Commentaries |
|
Impact of antiretroviral therapy on the relapse of cryptococcosis
and survival of HIV-infected Patients with cryptococcal infection. Jongwutiwes U, Kiertiburanakul S, Sungkanuparph S. Curr HIV Res. 2007 May;5(3):355-60. Abstract |
|
|
|
|
|
Cryptococcosis Drugs |